Histone deacetylase regulation of immune gene expression in tumor cells.

Immunologic Research
A Nazmul H Khan, Thomas B Tomasi

Abstract

Epigenetic modifications of chromatin, such as histone acetylation, are involved in repression of tumor antigens and multiple immune genes that are thought to facilitate tumor escape. The status of acetylation in a cell is determined by the balance of the activities of histone acetyltransferases and histone deacetylases. Inhibitors of histone deacetylase (HDACi) can enhance the expression of immunologically important molecules in tumor cells and HDACi treated tumor cells are able to induce immune responses in vitro and in vivo. Systemic HDACi are in clinical trails in cancer and also being used in several autoimmune disease models. To date, 18 HDACs have been reported in human cells and more than thirty HDACi identified, although only a few immune targets of these inhibitors have been identified. Here, we discuss the molecular pathways employed by HDACi and their potential role in inducing immune responses against tumors. We review data suggesting that selection of target specific HDACi and combinations with other agents and modalities, including those that activate stress pathways, may further enhance the efficacy of epigenetic therapies.

References

Mar 17, 1999·The Journal of Clinical Investigation·J J KimD B Weiner
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·W J MagnerT B Tomasi
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·N MishraG M Kammer
Mar 13, 2001·Annual Review of Immunology·W R Heath, F R Carbone
Jun 8, 2001·Annual Review of Biochemistry·S Y RothC D Allis
Aug 11, 2001·Science·T Jenuwein, C D Allis
Sep 27, 2001·The Journal of Biological Chemistry·L YinC Giardina
Feb 28, 2002·Annual Review of Immunology·Stephen T Smale, Amanda G Fisher
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Flavio LeoniPaolo Mascagni
Jul 26, 2002·Journal of the American Society of Nephrology : JASN·Zhiyuan YuBruce C Kone
Nov 14, 2002·The Biochemical Journal·Annemieke J M de RuijterAndré B P van Kuilenburg
Feb 18, 2003·The Journal of Clinical Investigation·Nilamadhab MishraGary S Gilkeson
Mar 19, 2003·European Journal of Clinical Investigation·P VerniaUNKNOWN Gruppo Italiano per lo Studio del Colon and del Retto
Apr 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Stephen J HaggartyStuart L Schreiber
Apr 25, 2003·Trends in Genetics : TIG·Eric VerdinHerbert G Kasler
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takayuki KanasekiNoriyuki Sato
Jun 28, 2003·FEBS Letters·Alison L Clayton, Louis C Mahadevan
Jun 28, 2003·Nature Immunology·K Mark AnselAnjana Rao
Aug 16, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lin-Feng Chen, Warner C Greene
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Erding HuMichael Jaye
Sep 27, 2003·Journal of Neurochemistry·Tiina SuuronenAntero Salminen
Nov 6, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yih Lin ChungLin Fen Yao
Nov 11, 2003·BMC Cancer·José Manuel Afonso MoreiraPoul Sørensen
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Inna Nusinzon, Curt M Horvath
Feb 19, 2004·British Journal of Cancer·S B HakeC D Allis
Mar 5, 2004·Cancer Immunology, Immunotherapy : CII·A Nazmul H KhanThomas B Tomasi
Mar 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pavan ReddyJames L M Ferrara
Mar 12, 2004·Cancer Letters·Florian R Greten, Michael Karin
May 5, 2004·The Journal of Biological Chemistry·Lidija KlampferLeonard Augenlicht
May 28, 2004·Nature·Gerda EggerPeter A Jones
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Jul 6, 2004·Journal of Immunotherapy·Stephen L AltieriThomas B Tomasi
Jul 23, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·L SandersonD M Vigushin
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher M ReillyGary S Gilkeson
Oct 2, 2004·Nature Reviews. Immunology·Yehudit Bergman, Howard Cedar

❮ Previous
Next ❯

Citations

Dec 17, 2010·Investigational New Drugs·Michael DickinsonH Miles Prince
Nov 23, 2011·Immunology and Cell Biology·Karrune V WoanAlejandro Villagra
Apr 22, 2011·Journal of Hematology & Oncology·Xiaoxin S XuGan Wang
Nov 11, 2010·Future Oncology·Milan Reiniš
Jan 16, 2016·Annual Review of Medicine·Nita AhujaStephen B Baylin
Sep 25, 2010·Leukemia Research·Jason A DubovskyJavier A Pinilla-Ibarz
Jul 25, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Madeleine S Q KortenhorstLuigi Marchionni
Oct 9, 2008·Current Opinion in Oncology·Min-Jung LeeJane B Trepel
Nov 8, 2008·Drugs in R&D·Anas Al-JanadiBarbara A Conley
Jun 27, 2009·Cancer Control : Journal of the Moffitt Cancer Center·Paul M HowellAdam I Riker
Mar 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongwei WangEduardo M Sotomayor
Aug 25, 2015·Cancer Immunology Research·David M WoodsJeffrey Weber
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S Schrump
Jan 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jhanelle E GraySoner Altiok
Jan 28, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nina J ChuElizabeth M Jaffee
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Haeryung ChoJaeho Bae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Cancer Immunology, Immunotherapy : CII
Thomas B TomasiA Nazmul H Khan
Current Opinion in Immunology
Margit H Lampen, Thorbald van Hall
© 2021 Meta ULC. All rights reserved